Tourette Syndrome and Its Comorbidities
This course will define Tourette syndrome, review the diagnostic criteria and review expected comorbidities.
Target Audience
Adult and Pediatric Neurologists, Neurosurgeons, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Neuropsychologists, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, Clinical Pharmacists, Rehabilitation and Pain Management Specialists, as well as other specialists interested in the field of neuroscience.
Learning Objectives
- Define the epidemiology of Tourette syndrome, and recognize core clinical features associated with this syndrome.
- Describe optimal therapeutic options for Tourette syndrome that will minimize any complications caused by comorbidities and their relevance.
Jorge L. Juncos, M.D.
Professor of Neurology
Emory University School of Medicine
Neurologist, Emory Clinic
Atlanta, Georgia
Jorge L. Juncos, M.D., faculty for this educational activity, indicated that he receives grant/research support from US World Meds, Adamas, Abbvie and Synovium, and serves as a consultant to Acadia Pharmaceuticals and Psydon. Also, Dr. Juncos is medical advisor of Tics of Georgia and the American Parkinson’s Disease Association of Georgia, and is on the advisory board of the Parkinson’s Disease Gladiators. Dr. Juncos receives research funding from the National Institutes of Health and the Michael J. Fox Foundation. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.
PLANNING COMMITTEE
Kevin Abrams, M.D., indicated that he is a consultant and shareholder with Keystone Heart.
Kiwon Lee, M.D., has no relevant financial relationship with ineligible companies* to disclose.
Guilherme Dabus, M.D., indicated that he is a consultant for Microvention/Terumo, Medtronic, Penumbra and Cerenovus, and on the speakers bureau for Microvention/Terumo, Medtronic and Penumbra. He is a proctor for Medtronic. Dr. Dabus is also a shareholder with Surpass Medical/Stryker, Medina/Medtronic, InNeuro Co and Three Rivers Medical.
Daniel D’Amour, M.D., Felipe De Los Rios, M.D., Karel Fuentes, M.D., Sergio Gonzalez-Arias, M.D., Ph.D., Kunal Patel, M.S., Amy K. Starosciak, Ph.D., and Jayme Strauss, R.N., MSN, have no relevant financial relationship with ineligible companies* to disclose.
Bruno V. Gallo, M.D., indicated that he is on speakers' bureau for Teva Pharmaceuticals and Sunovion Pharmaceuticals. He receives grant support for Medtronic International, Pfizer Pharmaceuticals, Glaxo-SmithKline and St. Jude Medical, Inc. Dr. Gallo serves as a consultant for Cyberonics, Teva Pharmaceuticals, St. Jude Medical, ONS Inc. and Sugimon LLC.
Italo Linfante, M.D., indicated that he is a consultant for Medtronic, Stryker and Penumbra. He is a stockholder with InNeuro Co.
Alberto Pinzon-Ardila, M.D., indicated that he is a member of the speakers' bureau for Sunovion and UCB Pharmaceuticals.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points.
NOTE: Maintenance of Certification (MOC) points will be automatically reported to the ABIM. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Available Credit
- 0.50 ABIM MOC II
- 0.50 AMA PRA Category 1 Credit™
- 0.50 General certificate of attendance
NOTE: Maintenance of Certification (MOC) points will be automatically reported to the ABIM. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |